News | December 26, 2023
AstraZeneca to acquire China's Gracell Biotechnologies for US $1.2 billion
Furthering cell therapy ambition across oncology and autoimmune diseases
Furthering cell therapy ambition across oncology and autoimmune diseases
US FDA approval based on NEURO-TTRansform Phase III results
The plant is yet to start commercial operations
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
Leading USA based genetic testing brand officially enters the Indian market
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Subscribe To Our Newsletter & Stay Updated
